Harnessing FGF-10 signaling to protect ER-stress alveolar epithelial cells against viral infection - impact on regenereration versus fibrosis
Harnessing FGF-10 signaling to protect ER-stress alveolar epithelial cells against viral infection - impact on regenereration versus fibrosis
批准号:
319878621
负责人:
Professor Dr. Saverio Bellusci
金额:
$0.0万
依托单位国家:
德国
项目类别:
Clinical Research Units
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
特发性肺纤维化(Idiopathic pulmonary fibrosis, IPF)是一种慢性、进行性、致死性肺实质疾病,被认为是由于衰老肺泡上皮2型细胞(AT2)的慢性损伤,如促凋亡内质网(ER)应激所致。成纤维细胞生长因子10 (FGF-10)已被证明对肺泡上皮谱系的形成和AT2在损伤反应中的存活具有重要作用。已知病毒感染可引发IPF的进展并使疾病加重。在之前的资助期内,我们发现microRNA miR-142与肺发育过程中AT2的形成有关,并受FGF-10调节。我们还发现,病毒感染er应激AT2增加细胞凋亡并促进肺纤维化。此外,我们发现FGF-10可阻止流感(PR8)在AT2中的扩增,敲除miR-142可使AT2对PR8更具抗性。此外,我们发现一线降糖药物二甲双胍影响FGF-10信号传导并加速损伤后肺再生。基于这些结果,我们提出,在即将到来的资助期内,新发现的成人肺中FGF-10-FGFR2b-miR-142信号轴可减少er应激AT2细胞的病毒感染,我们设想包括二甲双胍在内的靶向该轴对病毒诱导的肺损伤和再生有益。
英文摘要
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal parenchymal lung disease, which is proposed to originate from chronic injury to aged alveolar epithelial type 2 cells (AT2) such as pro-apoptotic endoplasmic reticulum (ER) stress. Fibroblast Growth Factor 10 (FGF-10) has been shown to be important for the formation of the alveolar epithelial lineage development and for survival of AT2 in response to injury. Viral infection is known to trigger progression of IPF and to aggravate the disease. In the preceding funding period, we identified the microRNA miR-142 to be linked with the formation of AT2 during lung development and to be regulated by FGF-10. We also showed that viral infection in the ER-stressed AT2 augments apoptosis and boosts lung fibrosis. Moreover, we found that FGF-10 prevents influenza (PR8) amplification in AT2 and that a knockout of miR-142 makes AT2 more resistant to PR8. Additionally, we showed that the first-line antidiabetic drug metformin impacts FGF-10 signaling and accelerates lung regeneration after injury. Based on these results, we propose, in the forthcoming funding period, that the newly discovered FGF-10-FGFR2b-miR-142 signaling axis in the adult lung decreases viral infection of ER-stressed AT2 cells, and we envision that targeting this axis including metformin administration beneficially impacts virus-induced lung injury and regeneration.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MicroRNA and Epithelial-Mesenchymal Interactions in Lung Development and Fibrosis
-
批准号:406538808
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2018
-
负责人:Professor Dr. Saverio Bellusci
-
依托单位:
FGF10/FGFR2b signaling in lung emphysema as a target for lung regeneration
-
批准号:269289029
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professor Dr. Saverio Bellusci
-
依托单位:
Fibroblast Growth factor signaling in lipofibroblast formation and transdifferentiation during normal lung development and fibrosis
-
批准号:230426931
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Saverio Bellusci
-
依托单位:
FGF10 signaling in distal/alveolar epithelial progenitor cells - role in lung fibrosis
-
批准号:161184405
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Professor Dr. Saverio Bellusci
-
依托单位:
Characterization of AT2 and LIF Heterogeneity and Role of Fgf10/Fgfr2b Signaling in the Maintenance of Adult Lung Homeostasis - Importance of Reciprocal Lipofibroblast/AT2 Stem Cell Interactions
-
批准号:506619863
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Saverio Bellusci
-
依托单位:
Molecular Bases of Activated Myofibroblast (MYF) to Lipofibroblast (LIF) Phenotype switching during Fibrosis Resolution.
-
批准号:435231213
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Saverio Bellusci
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于线粒体自噬探究 FGF10 介导 AMPK/ULK1信号通路在非酒精性脂肪性肝病中的作用机制
-
批准号:ZCLQN26H0303
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:汪洁
-
依托单位:
FGF10介导TBX20通路对小儿肥厚型心肌病病理重构的机制及干预研究
-
批准号:82500446
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:陈实
-
依托单位:
牙依附性Foxq1-Fgf10信号通路协同纳米
抑菌水凝胶促进牙槽骨再生的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:项露赛
-
依托单位:
肝内源性FGF10/FGFR2信号调控胆汁淤积性肝损伤的作用机制探究
-
批准号:MS25H310002
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李三铁
-
依托单位:
探索 Fgf10-FgfR2b 信号通路在干性 AMD 治疗中的潜力
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:王凤
-
依托单位:
FGF10通过靶点GPAT3调控脂质代谢治疗NASH肝纤维化的机制研究
-
批准号:82400681
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2024
-
负责人:杨选鑫
-
依托单位:
COLEC10通过FlnA/AR/FGF2信号通路抑制肝癌新生血管形成的机制研究及临床应用
-
批准号:82473007
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2024
-
负责人:陈鸣宇
-
依托单位:
NAT10调控FGF2的ac4C修饰重塑食管癌微环境促进转移的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:100.0万元
-
批准年份:2023
-
负责人:许雯雯
-
依托单位:
FGF-21 抗As 的新机制:TET2/NDUFB10/ROS 途径拮抗内皮细胞焦亡
-
批准号:2022JJ30502
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:李国华
-
依托单位:
迷走神经-α7nAChR通过PDGFRα+肺间质细胞来源的FGF10精细调控AT2分化轨迹促进肺损伤修复及其机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:陈小燕
-
依托单位: